ArticleThe Journal of international medical research2025
A novel cancer-associated fibroblast-related gene signature for predicting diffuse large B cell lymphoma prognosis using weighted gene co-expression network analysis and machine learning.
Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial Intelligence for Risk Stratification in Diffuse Large B-Cell Lymphoma: A Systematic Review of Classification Models and Predictive Performances.Medical sciences (Basel, Switzerland) · 2025Pooled it
- The emerging role of cancer-associated fibroblasts in hematological malignancies: from their influence on tumor progression and drug resistance to novel therapeutic opportunities.Clinical and experimental medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveOur objective was to investigate a novel cancer-associated fibroblast-related gene signature for predicting clinical outcomes in patients with diffuse large B cell lymphoma.MethodsThe cancer-associated fibroblast-related module genes were identified from Gene Expression Omnibus datasets using weighted gene co-expression network analysis in our retrospective study. Least Absolute Shrinkage and Selection Operator Cox regression was applied to screen a minimal set of genes and construct a prognostic cancer-associated fibroblast-related gene signature for diffuse large B cell lymphoma. Kaplan-Meier plots and receiver operating characteristic curves were used to assess the prognostic performance of the prognostic cancer-associated fibroblast-related genes. A nomogram encompassing the clinical information and prognostic scores of the patients was constructed. Additionally, the relationships of the gene signature with the immune landscape and drug sensitivity were explored.ResultsCapitalizing on machine learning, we developed a prognostic cancer-associated fibroblast-related gene signature risk model, efficiently categorizing patients with diffuse large B cell lymphoma into high- and low-risk groups and exhibiting a more robust capacity for survival prediction. The nomogram showed stronger prognostic ability than the clinical factor-based model or the risk score alone. We also observed significant differences in immune cell profiles and therapeutic responses between the two groups, offering valuable insights for developing personalized treatments for diffuse large B cell lymphoma.ConclusionsWe developed a prognostic cancer-associated fibroblast-related gene-based genetic risk model to predict the prognosis of diffuse large B cell lymphoma, potentially aiding in treatment selection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.